Abstract
Haloperidol (0.08 mg/kg) or fentanyl (0.16 mg/kg) injected subcutaneously suppressed bar-pressing for brain-stimulation in rats, implanted with electrodes in the lateral hypothalamic area of the medial forebrain bundle. Increasing doses: 0.04, 0.16, 0.63 and 2.50 mg/kg of the central anticholinergic dexetimide gradually antagonized the haloperidol effects. The highest dose of dexetimide did not reduce the fentanyl-induced inhibition. The results, together with a literature survey on the anticholinergic effects on neuroleptic-induced catalepsy and inhibition of avoidance behavior, are related to biochemical findings and clinical effects.
Similar content being viewed by others
References
Aghajanian, G. K., Bunney, B. S.: Central dopaminergic neurons: Neurophysiological identification and responses to drugs. In: Frontiers in catecholamine research, E. Usdin and S. Snyder, eds., pp. 643–648. New York: Pergamon Press 1973
Andén, N. E., Bédard, P.: Influence of cholinergic mechanisms on the function and turnover of brain dopamine. J. Pharm. Pharmacol. 23, 460–462 (1971)
Andén, N., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Europ. J. Pharmacol. 11, 303–314 (1970)
Bartholini, G., Pletscher, A.: Atropine-induced changes of cerebral dopamine turnover. Experientia 27, 1302–1303 (1971)
Bartholini, G., Stadler, H., Lloyd, K. G.: Cholinergic-dopaminergic relation in different brain structures. In: Frontiers in catecholamine research, E. Usdin and S. H. Snyder, eds., pp. 741–745. New York: Pergamon Press 1973
Bloom, F. E., Costa, E., Salmoiraghi, G. C.: Anesthesia and the responsiveness of individual neurons of the caudate nucleus of the cat to acetylcholine, norepinephrine and dopamine administered by microelectrophoresis. J. Pharmacol. exp. Ther. 150, 244–252 (1965)
Bowers, M. B., Roth, R. H.: Interaction of atropine-like drugs with dopamine-containing neurones in rat brain. Brit. J. Pharmacol. 44, 301–306 (1972)
Bunney, B. S., Walters, J. R., Roth, R. H., Aghajanian, G. K.: Dopaminergic neurons: effects of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. exp. Ther. 185, 560–571 (1973)
Carlton, P. L.: Cholinergic mechanisms in the control of behavior. In: Psychopharmacology—A review of progress, 1957–1967, D. H. Efron, J. O. Cole, J. Levine, and J. R. Wittenborn, eds., PHHS Pub. No. 1836, Washington, D.C., 1968
Castellano, C.: Effects of some anticholinergic drugs on water maze learned behavior in mice. Psychopharmacologia (Berl.) 21, 361–369 (1971)
Coyle, J. T., Snyder, S. H.: Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action. Science 166, 899–901 (1969)
Connor, J. D., Rossi, G. V., Baker, W. W.: Antagonism of intracaudate carbachol tremor by injections of catecholamines. J. Pharmacol. exp. Ther. 155, 545–551 (1967)
Consolo, S., Ladinsky, H., Garattini, S.: Effect of several dopaminergic drugs and trihexyphenidyl on cholinergic parameters in the rat striatum. J. Pharm. Pharmacol. 26, 275–277 (1974)
Corrodi, H., Fuxe, K., Lidbrink, P.: Interaction between cholinergic and catecholaminergic neurones in rat brain. Brain Res. 43, 397–416 (1972)
Costall, B., Olley, J. E.: Cholinergic- and neuroleptic-induced catalepsy: modification by lesions in the caudate-putamen. Neuropharmacology 10, 297–306 (1971a)
Costall, B., Olley, J. E.: Cholinergic- and neuroleptic-induced catalepsy: modification by lesions in the globus pallidus and substantia nigra. Neuropharmacology 10, 581–594 (1971b)
Geivers, H. A., Xhonneux, R., Wauquier, A., Van Nueten, J., Reneman, R.: Programmable stimulator for biomedical research. 4th Annual Meeting, Biomedical Engineering Society, paper 3, p. 12 (1973)
Haase, H. J.: Therapie mit Psychopharmaka und anderen psychotropen Medikamenten. Stuttgart-New York: F. K. Schattauer 1972
Haase, H. J., Janssen, P. A. J.: The action of neuroleptic drugs. A psychiatric, neurologic and pharmacological investigation. Amsterdam: North-Holland 1965
Hanson, H. M., Stone, C. A., Witoslawski, J. J.: Antagonism of the antiavoidance effects of various agents by anticholinergic drugs. J. Pharmacol. exp. Ther. 173, 117–124 (1970)
Hökfelt, T., Ljungdahl, å., Fuxe, K., Johansson, O.: Dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia. Science 184, 177–179 (1974)
Horn, A. S., Coyle, J. T., Snyder, S. H.: Catecholamine uptake by synaptosomes from rat brain. Mol. Pharmacol. 7, 66–89 (1971)
Hornykiewicz, O.: Dopamine (3-hydroxytyramine) and brain function. Pharmacol. Rev. 18, 925–964 (1966)
Janssen, P. A. J., Niemegeers, C. J. E.: The peripheral and central anticholinergic properties of benzetimide (R 4929) and other atropine-like drugs as measured in a new anti-pilocarpine test in rats. Psychopharmacologia (Bed.) 11, 231–254 (1967)
Janssen, P. A. J., Niemegeers, C. J. E., Dony, J. G. H.: The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats. Arzneimittel-Forsch. 13, 502–507 (1963)
Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K.H. L., Demoen, P., Lenaerts, F. M., Van Nueten, J. M., Van Wijngaarden, I., Brugmans, J.: Benzetimide and its optical isomers. Arzneimittel-Forsch. 21, 1365–1373 (1971)
Javoy, F., Agid, Y., Bouvet, D., Glowinski, J.: Changes in neostriatal DA metabolism after carbachol or atropine microinjections into the substantia nigra. Brain Res. 68, 253–260 (1974)
Klawans, H. L., Jr.: The pharmacology of extrapyramidal movement disorders. Basel: S. Karger 1973
Leslie, G. B., Maxwell, D. R.: Some pharmacological properties of thioproperazine and their modification by antiparkinsonian drugs. Brit. J. Pharmacol. 22, 301–317 (1964)
Lloyd, K. G., Stadler, H., Bartholini, G.: Dopamine and acetylcholine neurones in the striatal and limbic structures: effect of neuroleptic drugs. In: Frontiers in catecholamine research. E. Usdin and S. Snyder, eds., pp. 777–779. New York: Pergamon Press, 1973
Malatray, J., Simon, P.: Effets ≪psychotropes≫ de quelques antiparkinsoniens. J. Pharmacol. (Paris) 3, 325–342 (1972)
Morpurgo, C.: Effects of antiparkinson drugs on a phenothiazine-induced catatonic reaction. Arch. int. Pharmacodyn. 87, 84–90 (1962)
Morpurgo, C.: Antiparkinson drugs and neuroleptics. In: Progress in brain research, Vol. 16, Horizons in neuropsychopharmacology, W. A. Himwich and J. P. Schadé, eds., pp. 121–134. Amsterdam: Elsevier 1965
Morpurgo, C., Theobald, W.: Influence of antiparkinson drugs and amphetamine on some pharmacological effects of phenothiazine derivatives used as neuroleptics. Psychopharmacologia (Berl.) 6, 178–191 (1964)
O'Keeffe, R., Sharman, D. F., Vogt, M.: Effects of drugs used in psychosis on cerebral dopamine metabolism. Brit. J. Pharmacol. 38, 287–304 (1970)
Olds, M. E.: Alterations by centrally acting drugs of the suppression of self-stimulation behavior in the rat by tetrabenazine, physostigmine, chlorpromazine and pentobarbital. Psychopharmacologia (Berl.) 25, 299–314 (1972)
Olds, M. E., Ito, M.: Noradrenergic and cholinergic action on neuronal activity during self-stimulation behavior in the rat. Neuropharmacology 12, 525–539 (1973)
Puri, S. K., Lal, H.: Effects of morphine, haloperidol, apomorphine and benztropine an dopamine turnover in rat corpus striatum: Evidence showing morphine-induced reduction in CNS dopaminergic activity. Fed. Proc. 32, 758 (1973)
Puri, S. K., Lal, H.: Tolerance to the behavioral and neurochemical effects of haloperidol and morphine in rats chronically treated with morphine or haloperidol. Naunyn-Schmiedeberg's Arch. Pharmacol. 282, 155–170 (1974)
Puri, S. K., Reddy, C., Lal, H.: Blockade of dopaminergic receptors by morphine: Effect of haloperidol, apomorphine or benztropine. Res. Comm. Chem. Path. Pharmacol. 5, 389–401 (1973)
Schaumann, W., Kurbjuweit, H. C.: Beeinflussung verschiedener Wirkungen von Thiopropazat durch ein zentrales Stimulans. Arzneimittel-Forsch. (Drug Res.) 11, 343–350 (1961)
Schelkunov, E. L.: Integrated effects of psychotropic drugs on the balance of cholino-, adreno-, and serotonergic processes in brain as a basis of their gross behavioural and therapeutic actions. Activ. nerv. sup. (Praha) 9, 207–217 (1967)
Sigwald, J.: Thérapeutique des syndromes extrapyramidaux par les traitements classiques. In: Monoamines et noyaux gris centraux, J. De Ajuriaguerra and G. Gauthier, eds., pp. 369–378. Geneva-Paris: Georg et Masson 1971
Singh, M. M., Di Scipio, W. J.: Changes in staff anxiety and attitudes during a double blind study of haloperidol in acute schizophrenics within a structured milieu. J. nerv. ment. Dis. 155, 245–256 (1972)
Singh, M. M., Kay, S. R.: Therapeutic antagonism between neuroleptics and antiparkinsonism agents in schizophrenia and its prognostic and nosological significance. Communication at the IX C.I.N.P. Congress, Paris 1974
Singh, M. M., Smith, J. M.: Sleeplessness in acute and chronic schizophrenia-Response to haloperidol and antiparkinsonism agents. Psychopharmacologia (Berl.) 29, 21–32 (1973)
Snyder, S. K., Banerjee, S. P., Yamamura, H. I., Greenberg, D.: Drugs, neurotransmitters, and schizophrenia. Science 184, 1243–1253 (1974)
Stadler, A., Lloyd, K. G., Godea-Civia, M., Bartholini, G.: Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine. Brain Res. 55, 476–480 (1973)
Stein, L.: Chemistry of reward and punishment. In: Psychopharmacology: A review of progress, 1957–1967, J. O. Cole, J. Levine, and J. R. Wittenborn, eds., p. 105. Efron, D.H.U.S. Government Printing Office, Washington, D. C., 1968
Van Wijngaarden, I.: Benzetimide, a new anticholinergic agent (Thesis). Rotterdam: Drukkerij Bronder-Offset N.V. 1970
von Taeschler, M., Weidmann, H., Cerletti, A.: Zur Pharmakologie von Ponalid, einem neuen zentralen Anticholinergicum. Schweiz. med. Wschr. 92, 1542–1545 (1962)
Wauquier, A., Niemegeers, C. J. E., Geivers, H. A.: Intracranial self-stimulation in rats as a function of various stimulus parameters. I. An empirical study with monopolar electrodes in the medial forebrain bundle. Psychopharmacologia (Berl.) 23, 238–260 (1972)
Wauquier, A., Niemegeers, C. J. E., Lal, H.: Differential antagonism by naloxone of inhibitory effects of haloperidol and morphine on brain self-stimulation. Psychopharmacologia (Berl.) 37, 303–310 (1974)
Wauquier, A., Niemegeers, C. J. E.: Intracranial self-stimulation in rats as a function of various stimulus parameters. II. Influence of haloperidol, pimozide and pipamperone on medial forebrain stimulation with monopolar electrodes. Psychopharmacologia (Berl.) 27, 191–202 (1972)
Author information
Authors and Affiliations
Additional information
Visiting pharmacologist from Department of Pharmacology and Psychology, University of Rhode Island, Kingston, R.I., U.S.A.
Rights and permissions
About this article
Cite this article
Wauquier, A., Niemegeers, C.J.E. & Lal, H. Differential antagonism by the anticholinergic dexetimide of inhibitory effects of haloperidol and fentanyl on brain self-stimulation. Psychopharmacologia 41, 229–235 (1975). https://doi.org/10.1007/BF00428929
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00428929